When eye movement problems skew MS thinking tests

Credibility

Interest

Share:2 min read

Key Takeaway

Severe eye movement problems (called internuclear ophthalmoplegia, INO) can make some visual thinking tests look worse in people with MS, even if thinking ability is unchanged.

What They Found

Researchers tested 197 people with MS using both visual and listening-based thinking tests and measured eye movements with a special infrared method. Mild INO by itself did not change how people did on visual tests once disease factors were taken into account. However, more severe INO on the right side when looking left was linked to worse scores on two quick visual-processing tests (SDMT and CST). The hearing-based test (PASAT) was not affected, suggesting the problem is tied to tests that need fast eye movements. Over six years, a very small number who developed new right-sided INO seemed to drop on one visual test, but this disappeared after adjusting for other disease changes.

Who Should Care and Why

People with MS should know that if they have noticeable eye movement trouble, their scores on fast visual tests might be low because of the eyes, not their thinking. Caregivers and family can help by telling clinicians about any eye trouble so test results are interpreted correctly. Doctors and therapists should consider using listening-based tests or adjusting how they judge visual test scores when INO is present. This matters in everyday care because a low test score might otherwise lead to changes in treatment or support that aren’t needed. Think of it like a cracked speedometer: the car’s speed (thinking) may be fine, but the broken gauge (eye movement) makes the number look wrong.

Important Considerations

The study found effects mainly for more severe, right-sided INO when looking left, so mild or other types of INO may not cause problems. Only a few people developed new INO over time, so the long-term link is not certain. These results do not mean thinking is worse — they warn that some eye problems can make certain tests unfair or misleading.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Specific Symptoms MS Diagnostics Early Research

Article Topics:

Cognitive impairmentEye trackingInternuclear ophthalmoplegiaOculographySymbol digit modalities test

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News